Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$24,567,109
+$2,665,214 QoQ
Shares Held
97,628
-3.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#544
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HARTFORD INVESTMENT MANAGEMENT CO holds $163,737,278 across 9 Drug Manufacturers - General names. ABBV ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
43,731 | $52,452,277 | |
| 2 | JNJ |
Johnson & Johnson
|
133,096 | $33,802,391 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
97,628 | $24,567,109 | |
| 4 | MRK |
Merck & Co., Inc.
|
136,591 | $17,551,943 | |
| 5 | AMGN |
Amgen Inc
|
29,842 | $10,806,385 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
68,761 | $8,687,264 | |
| 7 | PFE |
Pfizer Inc
|
315,579 | $7,599,142 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
113,017 | $6,512,039 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,567,109 | 97,628 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $21,901,895 | 100,703 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $23,329,971 | 102,105 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $23,966,936 | 103,511 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $19,781,709 | 106,571 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $22,571,589 | 107,730 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $19,403,418 | 109,192 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $21,953,259 | 111,167 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $19,402,170 | 113,119 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $20,773,057 | 114,075 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $18,430,427 | 118,929 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $18,096,778 | 121,406 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $16,821,309 | 124,852 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $23,907,890 | 150,015 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $29,365,668 | 181,707 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $24,491,580 | 182,487 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $27,689,336 | 180,787 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $28,599,446 | 176,420 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $25,547,813 | 188,684 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $18,796,347 | 174,250 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $21,996,001 | 195,277 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $21,599,196 | 199,586 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $22,089,079 | 206,151 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $16,207,566 | 185,039 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $18,837,109 | 191,863 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $13,349,173 | 175,209 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||